secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker BG CIK 0001996862
other material confidence high sentiment neutral materiality 0.50

Bunge shareholders approve 2024 LTIP, elect directors, and authorize $2.72 dividend

Bunge Global SA

item 5.02item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001996862-24-000127
form_type
8-K
ticker
BG
cik
0001996862
company_name
Bunge Global SA
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:21.386867+00:00
generated_at
2026-06-01T21:50:42.737935+00:00
sec_items
["5.02", "5.07", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001996862-24-000127
json_url
https://secwatch.observer/filing/0001996862-24-000127.json
markdown_url
https://secwatch.observer/filing/0001996862-24-000127.md
text_url
https://secwatch.observer/filing/0001996862-24-000127.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1996862/000199686224000127/0001996862-24-000127-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1996862/000199686224000127/bg-20240515.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

0195a737d0e6b817b8866469535fc48b0bb6c4c6

Bunge Global SA shareholders approved Approve a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. at the 2024-05-16 meeting.

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

111e447953d9ff8311801a198f9bac37599ba6e9

Bunge Global SA shareholders approved Approve the 2024 Long-Term Incentive Plan. at the 2024-05-16 meeting.

The shareholders approved the 2024 Long-Term Incentive Plan. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 106,639,164 2,620,701 121,523 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

2c3d8f4444f7b61ff3bcce4dd0de2351182b26ce

Bunge Global SA shareholders approved Reelect Bernardo Hees as director. at the 2024-05-16 meeting.

Bernardo Hees 108,390,957 813,106 177,325 6,269,823 5f. Michael Kobori 108,416,498 869,559 95,331 6,269,823 5g.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

4156872de7d16a3ff63f5163f33cfedd7f5a38bf

Bunge Global SA shareholders approved Advisory vote to approve the Named Executive Officers' compensation under U.S. securities law requirements. at the 2024-05-16 meeting.

The shareholders passed an advisory vote to approve the Named Executive Officers' compensation under U.S. securities law requirements. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 105,647,812 3,591,495 142,081 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

47c5d35cfb22f4f8de87da1732305fe99002bfdf

Bunge Global SA shareholders approved Reelect Bernardo Hees as member of Human Resources and Compensation Committee. at the 2024-05-16 meeting.

Bernardo Hees 108,572,572 617,763 191,053 6,269,823 7b. Kenneth Simril 108,580,399 609,050 191,939 6,269,823 7c.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

4c5fa18713cd681c71e7b99ff1d61c3bad79468e

Bunge Global SA shareholders approved Reelect Henry “Jay” Winship as member of Human Resources and Compensation Committee. at the 2024-05-16 meeting.

Henry “Jay” Winship 107,803,638 1,386,604 191,146 6,269,823 8. The shareholders approved the 2024 Long-Term Incentive Plan.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

4d333c55d144d15df6ca9f9164f4a6281118f9ac

Bunge Global SA shareholders approved Reelect Gregory A. Heckman as director. at the 2024-05-16 meeting.

Heckman 108,512,694 753,346 115,348 6,269,823 5e. Bernardo Hees 108,390,957 813,106 177,325 6,269,823 5f.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

574397525ec7e6bf3c76bcb6f5320c1a049f347e

Bunge Global SA shareholders approved Reelect Mark N. Zenuk as director. at the 2024-05-16 meeting.

Zenuk 107,197,526 2,056,422 127,440 6,269,823 The shareholders elected the following 4 individuals listed below as directors, each for a term extending until completion of the 2025 annual general meeting, subject to and contingent upon the closing of the acquisition of Viterra Limited, as further described in the Company's 2024 Proxy statement.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

65ebe005ad6baed9f3f0fd8c5a9324c63da95c68

Bunge Global SA shareholders approved Reelect Henry (Jay) Winship as director. at the 2024-05-16 meeting.

Henry (Jay) Winship 107,674,974 1,528,687 177,727 6,269,823 5j. Mark N. Zenuk 107,197,526 2,056,422 127,440 6,269,823 The shareholders elected the following 4 individuals listed below as directors, each for a term extending until completion of the 2025 annual general meeting, subject to and contingent upon the closing of the acquisition of Viterra Limited, as further described in the Company's 2024 Proxy statement.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

6ac542116cbd59eadf6219df2ed75a1e82e3dd2c

Bunge Global SA shareholders approved Elect Anne Jensen as director (contingent upon closing of acquisition). at the 2024-05-16 meeting.

Anne Jensen 109,090,587 83,645 207,156 6,269,823 5m. Christopher Mahoney 109,092,596 79,369 209,423 6,269,823 5n.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

7acc10606c61c29bab2b0db285771fc68c7edfc9

Bunge Global SA shareholders approved Elect the Swiss Statutory Independent Voting Representative. at the 2024-05-16 meeting.

The shareholders elected the Swiss Statutory Independent Voting Representative. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions 115,336,767 72,570 241,874

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

7b33d5753e18183d37bcf60e3512b2003cb7cb21

Bunge Global SA shareholders approved Reelect Kenneth Simril as director. at the 2024-05-16 meeting.

Kenneth Simril 108,217,690 985,187 178,511 6,269,823 5i. Henry (Jay) Winship 107,674,974 1,528,687 177,727 6,269,823 5j.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

7ca9a16a4d0fe390eff565b24280e3dd75697f8e

Bunge Global SA shareholders approved Approve appropriation of earnings for fiscal year 2023. at the 2024-05-16 meeting.

The shareholders approved the appropriation of earnings for fiscal year 2023. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,468,056 36,427 146,728

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

7e4c9bd23bccee20cb2009f16f61ee6ad7ebf66f

Bunge Global SA shareholders approved Elect Christopher Mahoney as director (contingent upon closing of acquisition). at the 2024-05-16 meeting.

Christopher Mahoney 109,092,596 79,369 209,423 6,269,823 5n. Markus Walt 109,105,453 130,318 145,617 6,269,823 6.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

8366e061a8cf1405edb4f66bfca018363e79e36c

Bunge Global SA shareholders approved Reelect Kenneth Simril as member of Human Resources and Compensation Committee. at the 2024-05-16 meeting.

Kenneth Simril 108,580,399 609,050 191,939 6,269,823 7c. Henry “Jay” Winship 107,803,638 1,386,604 191,146 6,269,823 8.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

92df68b1731e5c9803a76aabbfee8004e55f8b32

Bunge Global SA shareholders approved Elect Markus Walt as director (contingent upon closing of acquisition). at the 2024-05-16 meeting.

Markus Walt 109,105,453 130,318 145,617 6,269,823 6. The shareholders reelected Mark Zenuk as the Chair of the Board.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

a6b3cf404226875c1f16dacdefe414ecc56b2f04

Bunge Global SA shareholders approved Reelect Sheila Bair as director. at the 2024-05-16 meeting.

Sheila Bair 107,876,244 1,384,363 120,781 6,269,823 5c. Carol M. Browner 102,259,760 6,980,686 140,942 6,269,823 5d.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

aabbf911b2cd1be3eb3df4744ef31250f11d6c1d

Bunge Global SA shareholders approved Approve the discharge of the members of the Board and the Executive Management Team from liability for activities during fiscal year 2023. at the 2024-05-16 meeting.

The shareholders approved the discharge of the members of the Board and the Executive Management Team from liability for activities during fiscal year 2023. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 108,056,783 888,619 435,986 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

b18c8f8bd4b48bd209960d3f5692fa369d66e927

Bunge Global SA shareholders approved Approve the maximum aggregate compensation of the Board for the period between the 2024 annual general meeting and the 2025 annual general meeting. at the 2024-05-16 meeting.

The shareholders approved the maximum aggregate compensation of the Board for the period between the 2024 annual general meeting and the 2025 annual general meeting. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 108,748,937 484,100 148,351 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

c02623f2405867bed5234cabd3f0c67503abd9c9

Bunge Global SA shareholders approved Elect Adrian Isman as director (contingent upon closing of acquisition). at the 2024-05-16 meeting.

Adrian Isman 109,092,803 79,826 208,759 6,269,823 5l. Anne Jensen 109,090,587 83,645 207,156 6,269,823 5m.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

c4cfd120c0b6c5c92bb9004a906652c662367af8

Bunge Global SA shareholders approved Approve the maximum aggregate compensation of the Executive Management Team for the fiscal year 2025. at the 2024-05-16 meeting.

The shareholders approved the maximum aggregate compensation of the Executive Management Team for the fiscal year 2025. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 107,151,167 2,076,301 153,920 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

c8e3f4b6959cbf5f64f0ea0609708d93be5cd8a6

Bunge Global SA shareholders approved Reelect Mark Zenuk as Chair of the Board. at the 2024-05-16 meeting.

The shareholders reelected Mark Zenuk as the Chair of the Board. The tabulation of votes with respect to the reelection of the Chair of the Board was as follows: Votes For Votes Against Abstentions Broker Non-Votes 108,263,590 976,526 141,272 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

cd87247599697a2afef9cf6b18fecd52688c7b94

Bunge Global SA shareholders approved Reelect Michael Kobori as director. at the 2024-05-16 meeting.

Michael Kobori 108,416,498 869,559 95,331 6,269,823 5g. Monica McGurk 107,936,421 1,306,725 138,242 6,269,823 2 5h.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

d2a7fe8087f0734894e1d9e32cfd9d666c551b3a

Bunge Global SA shareholders approved Reelect Eliane Aleixo Lustosa de Andrade as director. at the 2024-05-16 meeting.

Eliane Aleixo Lustosa de Andrade 108,479,370 811,847 90,171 6,269,823 5b. Sheila Bair 107,876,244 1,384,363 120,781 6,269,823 5c.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

d68fe2d898239d33ded57d44677505d3ca1fd2a8

Bunge Global SA shareholders approved Approve Swiss statutory consolidated financial statements and Swiss standalone financial statements of the Company for the year ended December 31, 2023. at the 2024-05-16 meeting.

The shareholders approved the Swiss statutory consolidated financial statements and Swiss standalone financial statements of the Company for the year ended December 31, 2023. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,170,907 52,825 427,479

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

e33c5ed74469a1f64e3ed332073b3d0a9308b010

Bunge Global SA shareholders approved Reelect Monica McGurk as director. at the 2024-05-16 meeting.

Monica McGurk 107,936,421 1,306,725 138,242 6,269,823 2 5h. Kenneth Simril 108,217,690 985,187 178,511 6,269,823 5i.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

e46e5dc7d74b82aed5b1918b7a80d07b335d416c

Bunge Global SA shareholders approved Reelect Carol M. Browner as director. at the 2024-05-16 meeting.

Browner 102,259,760 6,980,686 140,942 6,269,823 5d. Gregory A. Heckman 108,512,694 753,346 115,348 6,269,823 5e.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

f774d0d603b3c09b43c633991e4838d7dc0624fb

Bunge Global SA shareholders approved Advisory vote on the Swiss Statutory Non-Financial Matters Report. at the 2024-05-16 meeting.

The shareholders passed an advisory vote on the Swiss Statutory Non-Financial Matters Report. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 106,988,498 1,937,309 455,581 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

fd2445ea4342ff77905d41bb22961b7c71c37b3f

Bunge Global SA shareholders approved Reelect the independent auditor for U.S. securities law purposes and the statutory auditor for Swiss law purposes. at the 2024-05-16 meeting.

The shareholders reelected the independent auditor for U.S. securities law purposes and the statutory auditor for Swiss law purposes. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions 108,129,589 7,360,004 161,618

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

fe778053979fe72af662535bcdfd44541aa5ce33

Bunge Global SA shareholders approved Advisory vote on the Swiss Compensation Report. at the 2024-05-16 meeting.

The shareholders passed an advisory vote on the Swiss Compensation Report. The tabulation of votes with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Votes 105,641,316 3,559,140 180,932 6,269,823

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

Comparable filings

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

Advisory vote to approve the fiscal 2026 compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 493,864,228 117,716,717 668,510 102,463,325

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

PROPOSAL 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for calendar year 2026. Votes For Votes Against Abstentions 134,853,955 7,100,190 646,621

Filing page SEC filing

SIRI

Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors

SIRIUS XM HOLDINGS INC. June 1, 2026, 4:28 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

Item 2 – Advisory Vote on Named Executive Officer Compensation The holders of our common stock approved, on a non-binding advisory basis, the compensation paid to our named executive officers. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 228,280,853 4,764,836 1,349,137 51,448,019

Filing page SEC filing

ESPR

Esperion shareholders approve 7M-share increase to 2022 equity incentive plan

Esperion Therapeutics, Inc. June 1, 2026, 4:22 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 167,083,447 8,765,273 1,360,136 —

Filing page SEC filing

LUV

Southwest shareholders approve amended equity plan with 4.75M share increase; all directors elected

SOUTHWEST AIRLINES CO May 20, 2024, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

3. Proposal 3 – Approval of the Southwest Airlines Co. Amended and Restated 2007 Equity Incentive Plan: VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 408,346,613 28,870,401 1,635,532 90,613,942

Filing page SEC filing

Regulus Therapeutics Inc.

Regulus shareholders approve 2019 Equity Plan amendment adding 9.5M shares

Regulus Therapeutics Inc. May 17, 2024, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

Proposal 5. The Company’s stockholders approved the Amended 2019 Plan which, among other things, increased the number of shares of our common stock authorized for issuance under the 2019 Plan by 9,500,000 shares and modified the calculation of the annual automatic share reserve increase to take into account shares of common stock issuable upon conversion or exercise of convertible preferred stock and prefunded warrants. Votes For Votes Against Abstentions Broker Non-Votes 32,563,555 5,916,084 29,301 3,688,130

Filing page SEC filing

OSUR

OraSure shareholders approve 3M share increase in stock plan, charter amendment limiting officer liability

ORASURE TECHNOLOGIES INC May 17, 2024, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

ITEM 1 . Election of two Class III Directors for Terms Ending in 2027. NAME Votes For Votes Against Abstentions Broker Non-Votes Nancy J. Gagliano, M.D. 57,243,711 4,832,639 46,575 5,007,157 Lelio Marmora 57,332,773 4,732,865 57,287 5,007,157

Filing page SEC filing

Nemaura Medical Inc.

Shareholders approve reverse stock split authorization at ratio of 1:10 to 1:150

Nemaura Medical Inc. May 17, 2024, 7:59 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The shareholders approved a cash dividend in the aggregate amount of U.S. $2.72 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows: Votes For Votes Against Abstentions 115,450,866 88,580 111,765

Comparable filing

On May 9, 2024, the Shareholders of Nemaura Medical Inc. (the “Company”) approved by written consent to authorize amendments to the Articles of Incorporation of the Company (the “Articles”) to effect a reverse stock split of the common stock, par value $0.001 per share, of the Company (the “Common Stock”) ranging in ratio between 1-for-10 and 1-for-150, with one share of Common Stock being issued for a range of between each 10 and 150 shares of Common Stock issued and outstanding, with such final ratio to be determined by the Board following approval thereof by the shareholders of the Company, with any fractional shares of Common Stock resulting therefrom being rounded up to the nearest whole share of Common Stock (the “Reverse Split”), and to amend the Articles to effect the Reverse Split.

Filing page SEC filing

Source: SEC EDGAR
accession 0001996862-24-000127
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.